APOB and familial hypercholesterolemia: In total, twenty-three adult volunteers with mild hypercholesterolemia (fasting LDL-C≥100mg/dl) were enrolled, of whom 17 were exposed to Apo-B SNALP (Apo-B siNA in an LNP formulation) and the rest to placebo.